Acute quadriplegia myopathy in the intensive care unit: Time to look at a mechanistic approach

Critical Care Medicine

Volumn 28, Issue 1, 2000, Pages 260-261

  Zwienenberg, Marike ^b   Muizelaar, J Paul ^a,b  

^a University of California ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute quadriplegia; Corticosteroids; Muscle myosin; Neuromuscular blocking agents

Indexed keywords

ACTIN; ANALGESIC AGENT; CORTICOSTEROID; DEXAMETHASONE; MESSENGER RNA; MYOSIN; NEUROMUSCULAR BLOCKING AGENT; SEDATIVE AGENT; TIRILAZAD;

EDITORIAL; HUMAN; INTENSIVE CARE UNIT; MYOPATHY; NONHUMAN; PRIORITY JOURNAL; QUADRIPLEGIA;

EID: 0033953335     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200001000-00049     Document Type: Editorial

References (15)

1. 1. MacFarlane IA, Rosenthai FD. Severe myopathy after status asthmaticus. Lancet 1977; ii:615
2. 2. Dalakas MC. Inflammatory and toxic myopathies. Curr Opin Neural Neurosurg 1992; 5:645-654
3. 3. Leatherman JW, Fluegel, WL, David WS, et al: Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med 1996; 153:1668-1690
4. 4. Rouleau G, Karpati G, Carpenter S, et al: Glucocorticoid excess induces preferential depletion of myosin in denervated skeletal muscle fibers. Muscle Nerve 1987; 10:428-438
5. 5. DuBois DC, Almon RR. A possible role for glucocorticoids in denervation atrophy. Muscle Nerve 1981; 4:370-373
6. 6. Dubowitz V, Sewry CA, Fitzsimons RB: Muscle biopsy, a practical approach. Philadelphia, PA, Bailliere Tindall, 1985, pp 85-152
7. 7. Danon MJ, Carpenter S: Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991; 14: 1131-1139
8. 8. Wacklawik AJ, Sufit RL, Beinlich BR, et al: Acute myopathy with selective degeneration of myosin filaments following status asthmaticus treated with methylprednisolone and vecuronium. Neuromuscul Disord 1992; 2:19-26
9. 9. Hirano M, Ott BR, Raps EC, et al: Acute quadriplegic myopathy: A complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology 1992; 42:2082-2087
10. 10. Barohn RJ, Jackson CE, Rogers SJ, et al: Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids. Muscle Nerve 1994; 17:647-654
11. 11. Larsson L, Li X, Edström L, et al: Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuro-muscular blocking agents and corticosteroids: Mechanisms at the cellular and molecular levels. Crit Care Med 2000; 28:34-45
12. 12. Rich MM, Teener JW, Raps EC: Muscle is electrically inexcitable in acute quadriplegic myopathy. Neurology 1996; 46:731-736
13. 13. Fisher JR, Baer RK: Acute myopathy associated with combined use of corticosteroids and neuromuscular blocking agents. Ann Pharmacother 1996; 30:1437-1445
14. 14. Shapiro BA, Warren J, Egol AB, et al: Practice parameters for sustained neuromuscular blockade in the adult critically ill patient: An executive summary. Crit Care Med 1995; 23: 1601-1605
15. 15. Bullock R, Chesnut RM, Clifton G, et al: Guidelines for the management of severe head injury. American Association of Neurological Surgeons and Brain Trauma Foundation, 1995